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Background: The aim of centralizing rectal cancer surgery in Catalonia (Spain) was to improve the quality of
patient care. We evaluated the impact of this policy by assessing patterns of care, comparing the clinical audits
carried out and analysing the implications of the healthcare reform from an organizational perspective. Methods:
A mixed methods approach based on a convergent parallel design was used. Quality of rectal cancer care was
25 assessed by means of a clinical audit for all patients receiving radical surgery for rectal cancer in two time periods
(2005–2007 and 2011–2012). The qualitative study consisted of 18 semi-structured interviews in September–
December 2014, with healthcare professionals, managers and experts. Results: From 2005–2007 to 2011–2012,
hospitals performing rectal cancer surgery decreased from 51 to 32. The proportion of patients undergoing
surgery in high volume centres increased from 37.5% to 52.8%. Improved report of total mesorectal excision
30 (36.2 vs. 85.7), less emergency surgery (5.6% vs. 3.6%) and more lymph node examinations (median: 14.1 vs. 16)
were observed (P< 0.001). However, centralizing highly complex cancers using different critical masses and
healthcare frameworks prompted the need for rearticulating partnerships at a hospital, rather than disease,
level. Conclusion: The centralization of rectal cancer surgery has been associated with better quality of care
and conformity with clinical guidelines. However, a more integrated model of care delivery is needed to
35 strengthen the centralization strategy.
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Introduction
European health systems are increasingly developing centralizedcare models as a way to improve quality of care for complex
40 procedures and rare cancers.1 Some experiences have attested that
centralizing procedures can improve clinical outcomes,2 increasing
compliance with clinical practice guidelines (CPGs)3 and
organizational recommendations from cancer plans.4 In Catalonia,
Spain, the centralization strategy has been accompanied by a build-
45 up framework, consisting of the designation of authorized centres
(ACs) and the use of clinical audits to monitor outcomes. The policy
encompasses care for 10 cancers; among these, rectal cancer should
be considered a sentinel disease because of its incidence and the need
for a multidisciplinary approach, including multimodal therapy. The
50 early policy positioning on rectal cancer stemmed from both the
efforts made in the development and update of CPGs in 2003 and
2008, and the performance of a clinical audit in 2010 that focused on
the quality of surgery.5 The audit reported a higher adherence to
CPGs and better clinical outcomes in high-volume centres,
55 supporting the concentration of rectal cancer surgery.
These developments have also been influenced and complemented
by work elsewhere. For instance, the European Registration of
Cancer Care (EURECCA) has established guidelines as well as a
European framework for clinical audit.6 The Spanish Society of
60 Surgery has also run the Viking Project for rectal cancer since
2006; it includes an extensive training component for specialists
and has shown a local relapse rate comparable to that of Norway
in participating hospitals.7
Two years after the implementation of centralized rectal cancer
65 surgery in 2012, a second audit assessed the immediate effect on
clinical outcomes. However, the new regionalized model of cancer
care also entailed multiple implications and challenges for clinicians,
providers and healthcare system managers. We evaluated the impact
of rectal cancer care centralization by means of two complementary
70research goals: assessing patterns of care based on a comparison of
clinical audits between the two time periods, and understanding the
reform and its implementation from an organizational perspective.
Methods
Study context and overview
75The centralization strategy was implemented to improve patient
access to expert care,8 displacing the traditional model of cancer
care delivery, which allowed smaller hospitals to provide specialized
procedures requiring extensive clinical expertise with little to no
coordination with tertiary hospitals. A 2010 retrospective cohort
80study (for 2005 and 2007) reported that the wide scattering of
specialized surgical procedures for rectal cancer concealed poor
outcomes among many public providers. A specific regulation
underpinned on this assessment led to a surgery-centred
centralization, based on the following conditions: authorization of
85reference centres performing at least 11 surgeries per year, with a
referral system for those not authorized to provide the service; non-
reimbursement if the procedure is carried out in unauthorized
centres; and a ban on ‘adding up patients’ between centres in
order to reach the threshold for authorization. After the regulation
90was enacted in 2012, a three-month period for implementation was
allowed. Moreover, the results of the 2010 audit were communicated
individually to each of the participating centres in order to point out
specific processes and results requiring improvements.
We used a mixed-methods approach based on a convergent
parallel design, independently collecting and analysing quantitative
5 and qualitative data and then combining the findings in the final
interpretation.9 Qualitative analysis was added sequentially as a
second strand in order to provide a more comprehensive account
of the centralization strategy for rectal cancer surgery,10 by giving a
sense of process and contextual understanding to the quantitative
10 results of the clinical audit.11
Clinical audit assessment
We assessed quality of rectal cancer care by means of a clinical audit
for all patients undergoing rectal cancer surgery with a radical intent
in two time periods (2005–2007 and 2011–2012). We defined quality
15 of care as adherence to the Catalan CPG,12 which incorporate the
EURECCA recommendations. The methodology used has been
described in detail elsewhere.5 Differences in patterns of care
quality between the two time periods were assessed using the
U-Mann–Whitney test for continuous variables and the 2 test
20 and Fisher´s exact test for categorical variables. Two-sided P values
below 0.05 were deemed statistically significant. All analyses were
performed using SPSS software (version 21.0, 2012). We used the
Catalonian Hospital Discharge Minimum Basic Data Set to collect
data from 2014.
25 Qualitative evaluation
The qualitative portion of the study consisted of semi-structured
interviews conducted from September to December 2014, with
healthcare professionals involved in rectal cancer care (n=9),
hospital and health system managers (n= 7) and experts from
30 academia (n=2). The following criteria were used for selection of
informants and composition of the purposive sample: three
healthcare areas (Barcelona, Lleida and Manresa); ACs and non-
ACs; and different specialties including pathologists, gastroenterolo-
gists, surgeons and medical and radiation oncologists. Snowball
35 sampling was also used, especially among healthcare professionals.13
A semi-structured, one-on-one interview (by JP and PM) ensured
that all critical points were addressed and that the 45–60min sessions
were flexible enough to enable participants to volunteer information
on topics relevant to them. Interviews were audio-taped, transcribed
40 and then compiled into an anonymized documentary record. We
examined interview data inductively, applying thematic analysis
criteria to emphasise meaning and facilitate the interpretation of the
text’s thematic content.14 The development of inductive data codes
ensured that recurring views and experiences were obtained.15
45 Saturation of information was achieved.16 The Atlas-ti 6.2 software
programme facilitated a systematic process of data-treatment
analysis.17 We checked coding and interpretation consistency during
analysis by reviewing the transcripts at different points in time.
Results
50 Quantitative assessment
From 2005–2007–2012, the number of hospitals performing rectal
cancer surgery decreased from 51 to 32 centres. Between the two
study periods, the number of centres whose yearly volume of
surgical patients was more than 40 increased from 6 to 10, and
55 the proportion of patients receiving care in these centres rose
from 37.3% to 52.8%. By contrast, the number of centres with
fewer than 11 surgeries per year decreased from 25 to 6 (see
figure 1). Key surgical and pathology characteristics are shown and
stratified by study period in table 1: first (n=1831) and second study
60 period (n= 1949). No significant differences were identified in the
distribution of included and excluded patients. With regard to
surgery, no global change in the distribution of types of operation
occurred. The report of total mesorectal excision (TME) from path-
ologists improved. The proportion of complete mesorectum
65increased among the patients with reported mesorectal excision.
Also, patients having at least 12 lymph nodes examined improved,
as the median and mean number of lymph nodes examined
increased. Regarding circumferential radial margin (CRM), both
proportions of negative and positive resulting margins increased
70between periods, and the proportion of missing values decreased
(P< 0.001).
Of the six centres with fewer than 11 cases in 2012, three have
recently received authorization and have increased their volume
(due to the assignment of a larger catchment area and population),
75while the other three have seen their authorization rescinded and have
stopped offering this procedure. Thus, two years were necessary to
achieve nearly full compliance to the regulation. According to admin-
istrative data, 1039 patients underwent surgery in 32 centres in 2014.
Of these, 10 centres had a case volume exceeding 40 per year, and 2
80handled fewer than 11 cases.
Qualitative assessment
Most of the stakeholders involved expressed a favourable view
towards the centralization of rectal cancer surgery. Far from being
a neutral process, however, numerous implications emerged in
85relation to the use of clinical audits and the reconfiguration of
cancer services following the reform.
Using clinical audits as a service improvement
guidance
Clinical audits embody the quality control system of the
90centralization strategy, and different perspectives arose with
regards to their use. First, as critical mass is only a surrogate
marker of quality, many participants recommended reinforcing
and specifying the quality indicators to be used in clinical audits.
For instance, data show that multidisciplinary teams (MDTs)
95assessed 73% of patients were assessed by multidisciplinary teams
(MDTs), but it is unknown whether this was before any treatment
was delivered. Likewise, 12% of patients received neoadjuvant
chemotherapy by a non-AC’s team prior to surgery, but it is
unknown whether the surgical team agreed with such a decision.
100Complementary to auditing data by centre, interviewees
mentioned the need to carry out internal controls, specifically
disambiguating the results by surgeon and other key professionals,
and to develop a more managed approach with regard to suboptimal
clinical outcomes, which should lead to increased oversight or even
105rescission of the centre’s authorization. Also, more cooperation
should be fostered between nearby centres just surpassing the cut-
off point in order to share expertise and integrate clinical practice for
Figure 1 Distribution of centres, by annual volume of surgical
patients and time period
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both critical masses of patients. Overall, while centralization
ameliorated a significant part of existing therapeutic inequities,
half of the interviewees, regardless of their specialty or geographic
location, recommended raising the threshold set at 11 annual cases.
5 Although comparisons are problematic, the centralization carried
out for rare tumours such as sarcoma—restricted to 3 ACs,
contrasts with the high number of 32 ACs in rectal cancer, with
the latter model seen as being hindered by a significant scattering
of therapeutic procedures.
10 Another important issue was the difficulty in assessing quality of
care when centralization was based on a specific procedure.
Perceptions varied about whether rectal cancer is mainly surgeon-
dependent or if diagnostic and/or therapeutic procedures are also
key elements for clinical success. Thus, the clinical role assumed by
15 ACs and non-ACs, and the clinical criteria used to refer patients
(especially when lacking formal coordination mechanisms) showed
a significant variability. In this regard, most professionals from ACs
asserted the importance of pathology and imaging results being
assessed by the MDT undertaking treatments, especially in the case
20 of patients with advanced disease. On the contrary, professionals
from non-ACs argued the need to diagnose and stage patients in
their centres, in part to reduce waiting times in reference hospitals.
They also denounced the lack of devolution of patients for follow-up
in the non-ACs. On the other hand, most agreed on the need to
25 properly cope with acute complications and avoid a model of care
delivery based on the displacement of a skilled surgeon (currently
performed in paediatric or plastic surgery).
Regionalization of rectal cancer care and
organizational innovation
30 The top-down definition of a patient flow map prompted hospitals to
regionally create or reinforce inter-organizational relations in order to
manage the workflows. Before centralization, these connections lacked
a specific pattern, varied by cancer type and were mainly based on
informal relations between physicians of the same specialty, especially
35 medical oncologists and surgeons. In this context, our study revealed
two factors that gradually made the interface of ACs and non-ACs a
key management issue: first, the possibility to increase the critical mass
of patients by establishing agreements with hospitals that were not
originally considered in the referral map; and second, an explicit
40cultural shift in the customer-provider management, addressing
both patients’ transition and clinical engagement between profes-
sionals from different providers. Examples of such organizational
innovation, not only limited to rectal cancer, are described in
table 2. Interviewees identified multicentre tumour boards and
45cross-cutting groups as the most successful organizational
mechanisms for achieving integrated care. Importantly, both
examples depend on an institutionally supported clinical leader to
foster multicentre, win-win strategies and create shared ground for
partnership on treatment for rectal cancer patients. On the contrary,
50unsatisfactory experiences led some non-ACs to pressure central
health system managers to change the foreseen path, or they directly
referred patients to other ACs.
In another vein, some clinicians pointed to the fact that removing
competences on rectal cancer surgery disregarded the distribution of
55clinical expertise in the case of both skilled surgeons and other pro-
fessionals, arguing that ‘clinical expertise across the health system is
not limited to the staff working at authorized centres’. This led some
ACs to engage surgeons from non-ACs within an ongoing process of
satellitization between clinical departments/MDTs from different
60centres. Respondents also suggested taking advantage of specialist
expertise at a healthcare system level by optimizing their scale of
operation (e.g. tumour-site expert pathologists).
Discussion
This study showed the two sides of centralization: improved quality
65of cancer care, but also difficulties and debate on implementation at
the professional and management levels. In Catalonia, centralizing
rectal cancer surgery changed the prevailing healthcare patterns,
reducing the service providers from 51 to 32 hospitals. The
number of centres whose volume of surgical patients was under 11
Table 1 Indicators of rectal cancer surgery by audit period
2005/07 2011/12 P
n % n %
Cases included (n) 1831 1949
Treatment
Type of surgery Emergency 103 5.6 71 3.6 <0.001
Elective 1721 94.0 1878 96.4
Missing 7 0.4 – –
Surgical operation1 Anterior resection 615 34.2 527 28.4 <0.001
Low anterior resection 715 39.7 842 45.4
Abdoperineal resection 385 21.4 404 21.8
Hartmann´s procedure 85 4.7 80 4.3
Pathology (pathology report)
Mesorectal excision Reported 656 36.2 1606 85.7 <0.001
Not reported 1158 63.8 268 14.3
Quality of mesorectal excision M. Complete 419 63.9 1262 78.6 <0.001
M. Nearly complete 74 11.3 130 8.1
M. Incomplete 85 13.0 175 10.9
Missing 78 11.9 39 2.4
Lymph nodes examined 12 983 56.8 1213 66.5 <0.001
<12 749 43.2 611 33.5
Lymph nodes examined Mean  SD; median 14.1  9.6; 12 16.0  9.6; 14 <0.001
Lymph nodes affected Mean  SD; median 1.9  4.6; 0.0 1.4  3.5; 0.0 0.009
Lymph nodes index Mean  SD; median 11.6  21.5; 0.0 9.0  18.4; 0.0 0.003
(affected/examined)
Circumferential resection margin Negative 1468 84.7 1479 87.6 <0.001
Positive 113 6.5 138 8.2
Non assessed/missing 152 8.8 71 4.2
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decreased from 25 to 6, while high-volume centres (>40 surgical
patients per year) increased from 6 to 10 and eventually assumed
surgical care for over half of the patients. The Netherlands,18
Norway,19 and Sweden20 have also launched similar initiatives. For
5 instance, the number of providers in Norway dropped from 56
hospitals in 1993–97–36 in 2007–10; in the latter period, 69% of
patients underwent surgery in hospitals that performed > 25
operations per year. In Sweden, this figure rose from 50% in
1995–90% in 2012. Likewise, indicators for both surgical out-
10 comes and pathology processes in Catalonia improved after
centralization; for example, emergency surgical interventions
decreased to levels similar to those achieved in the Dutch
Surgical Colorectal Audit.18 Overall, there were no changes in the
proportion of sphincter-preserving surgery, probably due to its
15 perceived high value as a therapeutic target. In fact, the
proportion of conservative surgery in both study periods is higher
than the one obtained in other similar studies.21 This is consistent
with the high value assigned by patients to this strategy in southern
European countries.
20 Some data indicated a clear improvement in the quality of rectal
cancer care between the two periods. For example, TME is
considered the cornerstone of optimal surgical management for
patients with locally advanced rectal cancer, consistently related to
lower local recurrence rates;22 in our study, more pathologists
25 explicitly reported the performance of TME, which was especially
requested by health authorities after the first audit. Although results
seem positive, we cannot conclude that the quality of the technique
itself has improved due to the high proportion of missing values in
the first period. Pathological reporting of CRM, which is associated
30 with both risk of local recurrence and patient survival,23 has also
improved. Also because there was a higher proportion of missing
values for CRM in the first audit than in the second, it is difficult to
assess the outcome related to CRM, as the relative proportion of
both negative and positive CRMs increased. However, the finding
35 observed in the last audit is consistent with the Dutch audit18 and
slightly higher than that of the Norwegian Rectal Cancer project.19
Finally, the proportion of patients with a least 12 lymph nodes
examined, as recommended by TNM and NICE for correctly
staging rectal cancer, increased significantly.24 The mean and
40 median number of lymph nodes analysed increased significantly in
the second period of study. Furthermore, considering that prognosis
improves for every negative lymph node found, the reduction of the
lymph node ratio to 2 between the two study periods translates to a
substantial improvement in quality of care.
45 It took two years for regional hospitals to comply with the new
regulations, reflecting the complexities (including financial
constraints) that this kind of policy measure inevitably entails. A
reconfiguration of rectal cancer services based on regional linkages
emerged and shaped the centralization strategy, with clinical audits
50serving as the cornerstone of the reform. The audits not only
provided the scientific basis for centralization but also influenced
the established model of clinical accountability, henceforth subject
to formal standards and policy monitoring. Indeed, the impact of
the auditing process itself in improving clinical practice was quite
55important. Other authors have observed that integrating auditing
into the national quality assurance policy helped standardise the
measurement of quality of care.18 Certainly, there is a significant
association between high-volume hospitals and improved 5-year
survival for rectal cancer,25 although it has not been possible to
60establish a specific case threshold that is associated with better
clinical outcomes.26 As other authors have stated, critical mass
appears to depend on indirect and complex links between high
case volumes and better outcomes.21 However, considering the
importance of such a measure, some cancer plans have explicitly
65set up minimum volume thresholds.27 The critical mass in our
case was largely considered to be too low, so a substantial variability
in outcomes may still exist. Quality assessment is further
complicated by the fact that diagnosis and multimodal therapy is
fragmented by centre. In this regard, the fact that only 11 Catalonian
70hospitals provide radiotherapy shows the need to disperse patient
care when pre-operative radiochemotherapy is required; this was
true for 55% of all cases in our study (stages II–III).
The challenges encountered stimulated considerations on the need
for a territorial rearticulation based on partnerships between
75hospitals rather than between specialist units regarding highly
complex diseases or procedures. Divergent views revealed a
potential clash with regard to different organizational options;
while some interviewees defended centralizing treatment delivery
in a limited number of hospitals, others believed that creating a
80network structure could better improve clinical outcomes and
management of elderly and comorbid patients. Other issues
included facilitating access to MDTs and site specialists,28 allotting
time for MDT meetings,29 avoiding specialist isolation and enabling
hospitals to treat patients admitted on an emergency basis (especially
85as 30–45% of European patients are diagnosed when their cancers
are too advanced to be curable).
Some strengths and limitations must be taken into account when
assessing the results of this study. One limitation in the quantitative
data relates to its retrospective nature. This aspect was addressed by
90equipping a trained team of professionals with purpose-designed
instruments to ensure highly accurate data collection from
patients’ medical charts. For both study periods, hospital results
Table 2 Types of healthcare reorganization between authorized (ACs) and non-authorized centres (non-ACs) in streamlining professional
expertise and continuity of care
Healthcare reorganization type Specific practices
Multicentre tumour boards  Involvement of clinicians from non-ACs within multicentre tumour boards in ACs, including the presen-
tation of patients to be referred
 Involvement of clinicians from ACs in non-AC tumour boards, to provide expert advice and visit patients
eligible for referral
Coordination of the process of
care between ACs and non-ACs
 Development and adoption of a pathology-based clinical protocol in both ACs and non-ACs
 Agreement on the clinical management roles to be played by ACs and non-ACs throughout the diagnostic,
staging, treatment and follow-up phases, in order to better deal with fragmentation of care
 Definition of scenarios between ACs and referring centres in order to better tackle the management of
complications, emergencies, secondary effects and treatment sequels
Pooling services and exchanging professionals  Pooling cancer services by involving expert clinicians in other ACs in order to activate local staff
competencies
 Exchange of professionals to maintain clinical skills and expertise
Clinical accountability and information  Annual report by ACs to non-ACs on clinical performance for referred patients
 Common use of pathology-based clinical databases between ACs and non-ACs
 Identification of clear gatekeepers in ACs for patients and professionals, granting full access to clinical
and care information along the process of care, reporting specific changes in treatments and
elaborating a final report before devolution.
 Exchange of publications between and among professionals in ACs and non-ACs
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were individually presented to the respective centres, and their
feedback validated the results. Patients treated in private centres
were excluded. Also, clinical audits did not include data on
waiting times and travel distances, although they are very relevant
5 in the patient experience of care. However, future audits will assess
these measures. One strength of the qualitative study was the criteria
used for the composition of the sample, which included interviewees
from different specialties, healthcare areas and ACs and non-ACs.
Snowball sampling helped avoid bias in favour of clinicians with
10 opinions favourable to the reform. However, the limited number
of participants implicitly ruled out the possibility of capturing all
the best practices that might exist in the health system. By using a
qualitative strand after the clinical audit analysis, we intended to add
dimension to the quantitative findings.10
15 In conclusion, centralizing delivery and integrating a clinical audit
component to rectal cancer surgery has been associated with better
quality of care and conformity with clinical guidelines. However,
further policy criteria and measures should consider the challenges
in centralizing care for different cancers through different critical
20 masses and healthcare frameworks. Developing the current system
of authorized and non-authorized centres towards a more
coordinated setting, especially considering the use of a network
approach, is envisaged as a proper response.
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Key points
 Centralizing delivery and integrating a clinical audit
40 component to rectal cancer surgery has been associated with
better quality of care and conformity with clinical guidelines.
 The process of centralizing cancer diseases is not neutral
from a healthcare system organization perspective.
Together with quality of care outcomes, our study
45 examined its implementation at the professional and
management levels.
 Centralizing highly complex cancers using different critical
masses and healthcare frameworks prompt the need for
rearticulating partnerships at a hospital, rather than
50 disease, level.
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